Venkata Boppana, MD
Interventional Cardiology · Wichita, KSNPI 1215243175
Payments from drug & device makers
Across 255 payments — averaging $34.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abiomed$1K
- Abbott$734
- Pfizer$510
- Novartis$422
- Boston Scientific$297
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $3,618 |
| Abiomed | 12 | $1,133 |
| Abbott | 12 | $734 |
| Pfizer | 49 | $510 |
| Novartis | 27 | $422 |
| Boston Scientific | 3 | $297 |
| AstraZeneca | 7 | $251 |
| E.r. Squibb & Sons, L.L.C. | 15 | $232 |
| Actelion Pharmaceuticals US, Inc. | 7 | $202 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $166 |
| Shockwave Medical, Inc | 1 | $142 |
| Johnson & Johnson | 9 | $139 |
| Kestra Medical Technology Services, Inc. | 1 | $127 |
| Sanofi-aventis U.S. LLC | 9 | $122 |
| Merck | 6 | $110 |
| Regeneron Healthcare Solutions, Inc. | 5 | $100 |
| ZOLL Circulation Inc | 1 | $93 |
| Amgen | 5 | $85 |
| Cardiovascular Systems Inc. | 1 | $77 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $53 |
| Boehringer Ingelheim | 2 | $44 |
| Surmodics, Inc. | 4 | $36 |
| Cvrx, Inc. | 2 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Bayer | 1 | $19 |
| Lundbeck LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$8,846 in reported general payments places this provider in the 40th percentile of 55 interventional cardiology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Wichita
- Hussam FarhoudWichita$270K
- Maheedhar GedelaWichita$54K
- Christian HouraniWichita$17K
- Gaurav TyagiWichita$13K
- Ravi BajajWichita$10K
- Assem FarhatWichita$9K
- Alaa BouladWichita$8K
- Rohma ShaikhWichita$4K
- George ReaderWichita$4K
- Mohamed ElmassryWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.